Cargando…

Dalbavancin: novel candidate for COVID-19 treatment

Detalles Bibliográficos
Autores principales:	Hoffmann, Markus, Jin, Yeonhwa, Pöhlmann, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816554/ https://www.ncbi.nlm.nih.gov/pubmed/33473156 http://dx.doi.org/10.1038/s41422-020-00459-5

Ejemplares similares

Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment
por: Hoffmann, Markus, et al.
Publicado: (2022)

Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1
por: Hoffmann, Markus, et al.
Publicado: (2021)

Mutation D614G increases SARS-CoV-2 transmission
por: Arora, Prerna, et al.
Publicado: (2021)

Omicron: Master of immune evasion maintains robust ACE2 binding
por: Hoffmann, Markus, et al.
Publicado: (2022)

Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
por: Yu, Bin, et al.
Publicado: (2020)

A promising vaccine candidate against COVID-19
por: Wang, Xiwei, et al.
Publicado: (2020)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

What we have learned from COVID-19 pandemic?
por: Chen, Hsiu-Hsi, et al.
Publicado: (2021)

Dalbavancin: a novel antimicrobial
por: Chen, A Y, et al.
Publicado: (2007)

COVID-19 and Tuberculosis
por: Yang, Heng, et al.
Publicado: (2020)

Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020)

Early treatment for COVID-19
por: Du Toit, Andrea
Publicado: (2023)

The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022)

Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment
por: Daniels, Craig, et al.
Publicado: (2010)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
por: Yang, Jing, et al.
Publicado: (2020)

Pandemic number five – Latest insights into the COVID-19 crisis
por: Häfner, Sophia Julia
Publicado: (2020)

The Application of Corticosteroids in COVID-19: A Two-edged Sword
por: Li, Na, et al.
Publicado: (2020)

AIDing cancer treatment: Reducing AID activity via HSP90 inhibition
por: Rebhandl, Stefan, et al.
Publicado: (2015)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021)

Targeting glucose metabolism for treatment of COVID-19
por: Ardestani, Amin, et al.
Publicado: (2021)

Identifying candidate ALS-associated genes in yeast
Publicado: (2012)

A next‐generation vaccine for broader and long‐lasting COVID‐19 protection
por: Xi, Jinxiang, et al.
Publicado: (2022)

Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
por: Cesta, Maria Candida, et al.
Publicado: (2022)

Treatment of COVID-19 with MSCs: how does it work?
por: Keating, Armand
Publicado: (2021)

Novel discovery in roles of structural variations and RWP-RK transcription factors in heat tolerance for pearl millet
por: Huang, Bingru, et al.
Publicado: (2023)

Potential mechanisms by which impaired ketogenesis links metabolism to T‐cell dysfunction in patients with severe COVID‐19
por: Wang, Bin, et al.
Publicado: (2022)

Recent highlights on myocarditis, cardiovascular complications of COVID-19, and cardiomyopathies from the International Journal of Cardiology: Heart & Vasculature
por: Conti, Nicolina, et al.
Publicado: (2022)

From small studies to precision medicine: prioritizing candidate biomarkers
por: Gaile, Daniel P, et al.
Publicado: (2013)

The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis
por: Yang, Jing, et al.
Publicado: (2020)

Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
por: Ladanyi, Marc, et al.
Publicado: (2019)

DSSylation, a novel guide for protein degradation?
por: Gong, Cheng-Xin
Publicado: (2014)

Mining for novel antibiotics in the age of antimicrobial resistance
por: Udaondo, Zulema, et al.
Publicado: (2020)

The neuroprotective effects of human growth hormone as a potential treatment for amyotrophic lateral sclerosis
por: Chung, Jin-Young, et al.
Publicado: (2015)

A novel pig model capturing clinical symptoms of harlequin ichthyosis
por: Lee, Kiho
Publicado: (2019)

Dual functions of a novel effector in the plant and pathogen arms race
por: Lu, Han, et al.
Publicado: (2023)

Lignin Hydrogenolysis: Improving Lignin Disassembly through Formaldehyde Stabilization
por: Kärkäs, Markus D.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_73g0iu4cpth4qimi3j9u7fnkpr